Project Twenty21 publishes first findings on chronic pain

Project Twenty21 publishes first findings on chronic pain
Cannabis Health News

The first condition-specific findings from the UK observational study, Project Twenty21, have been published on chronic pain.  Data from over 900 chronic pain patients, enrolled on Drug Science’s Project Twenty21 (T21), has been published in the leading academic journal, Frontiers, this week. The first of two papers, explores how cannabis-based medicines can be used in the treatment of chronic pain, and gives an overview of the current patient demographic, as well as highlighting the key challenges facing those living with persistent pain. Project Twenty21 was launched by UK drug reform charity, Drug Science, in 2019 with the aim of building a database for the safety and efficacy of medical cannabis. There are currently over 2,600 patients enrolled in the study, of which over 50 per cent are prescribed cannabis for chronic pain. Who are pain patients in the UK? According to this new paper, of the 949 people reporting chronic pain as a primary condition, just over half were male, with an average age of 42-years-old. A range of cannabinoid products were prescribed to this group, with just under half being classified as high-THC flower. In addition, 92 per cent of those with a primary condition of chronic pain reported experiencing at least one co-morbid secondary condition, with over a third reporting up to six.  These include psychiatric conditions including anxiety and depression, which can also be treated with medical cannabis products. The majority of patients also reported using at least one other prescribed medication (69 per cent). According to lead author and head of research at Drug Science, Dr Anne Katrin Schlag, one of the key findings of the paper was the low quality of life among pain patients, compared to the general population.  Over half of the sample reported that they experience “severe or extreme problems due to…

Excerpt only …
READ MORE BELOW
Source : Project Twenty21 publishes first findings on chronic pain

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.